{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:38:57Z","timestamp":1792132737527,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disorder that affects women at their child bearing age. The exact etiology is uncertain, however the involvement of multiple genes and environmental interactions has been proposed for the advancement of PCOS. The aim of present study was to evaluate the association of <jats:italic>LHCGR<\/jats:italic> variants (rs2293275 and rs12470652) with PCOS in Punjab.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The present case\u2013control study comprised a total of 743 women (421 PCOS cases and 322 healthy controls). Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism technique (PCR\u2013RFLP). Biochemical analysis was carried out to measure the levels of cholesterol, High-density lipoprotein (HDL), Low-density lipoprotein (LDL), Very low-density lipoprotein (VLDL), triglycerides, testosterone, luteinizing hormone (LH) and follicle-stimulating hormone (FSH). All the statistical analysis was done using SPSS (version21, IBM SPSS, NY, USA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mutant genotype (AA) and mutant allele (A) of rs2293275 conferred 1.7 and 1.3 fold risk, respectively and mutant allele (C) of rs12470652 conferred 2.3 fold risks towards PCOS progression. Levels of cholesterol and triglycerides were elevated and HDL levels were lower in PCOS cases as compared to controls. Total testosterone and luteinizing hormone levels were also found to be higher in PCOS cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study postulated that <jats:italic>LHCGR<\/jats:italic> variants are playing a cardinal role in the progression of PCOS and can be used to assess the risk of PCOS in women of reproductive age.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-022-01251-9","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T15:02:52Z","timestamp":1672412572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Association analysis of LHCGR variants and polycystic ovary syndrome in Punjab: a case\u2013control approach"],"prefix":"10.1186","volume":"22","author":[{"given":"Sukhjashanpreet","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratneev","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Beri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"issue":"6","key":"1251_CR1","first-page":"375","volume":"15","author":"FZ Zangeneh","year":"2017","unstructured":"Zangeneh FZ, Naghizadeh MM, Masoumi M. Polycystic ovary syndrome and circulating inflammatory markers. International Journal of Reproductive BioMedicine. 2017;15(6):375.","journal-title":"International Journal of Reproductive BioMedicine"},{"issue":"4","key":"1251_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/cen.12621","volume":"82","author":"MP Lauritsen","year":"2015","unstructured":"Lauritsen MP, Pinborg A, Loft A, Petersen JH, Mikkelsen AL, Bjerge MR, Nyboe AA. Revised criteria for PCOS in WHO G roup II anovulatory infertility\u2013a revival of hypothalamic amenorrhoea? Clin Endocrinol. 2015;82(4):584\u201391.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"1251_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1071\/RD17255","volume":"30","author":"A Singh","year":"2018","unstructured":"Singh A, Bora P, Krishna A. Systemic adiponectin treatment reverses polycystic ovary syndrome-like features in an animal model. Reprod Fertil Dev. 2018;30(4):571\u201384.","journal-title":"Reprod Fertil Dev"},{"issue":"1","key":"1251_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"ESHRE TR","year":"2004","unstructured":"ESHRE TR, ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil steril. 2004;81(1):19\u201325.","journal-title":"Fertil steril."},{"issue":"5","key":"1251_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487\u2013525.","journal-title":"Endocr Rev"},{"issue":"1","key":"1251_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/09513590.2018.1498834","volume":"35","author":"J Zou","year":"2019","unstructured":"Zou J, Wu D, Liu Y, Tan S. Association of luteinizing hormone\/choriogonadotropin receptor gene polymorphisms with polycystic ovary syndrome risk: a meta-analysis. Gynecol Endocrinol. 2019;35(1):81\u20135.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"1251_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng.732","volume":"43","author":"ZJ Chen","year":"2011","unstructured":"Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, Li Z, You L, Zhao J, Liu J, Liang X. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome\u00a02p16.3, 2p21 and 9q33.3. Nat genet. 2011;43(1):55\u20139.","journal-title":"Nat genet."},{"issue":"1","key":"1251_CR8","doi-asserted-by":"publisher","first-page":"E185","DOI":"10.1210\/jc.2012-2471","volume":"98","author":"P Mutharasan","year":"2013","unstructured":"Mutharasan P, Galdones E, Pe\u00f1alver Bernab\u00e9 B, Garcia OA, Jafari N, Shea LD, Woodruff TK, Legro RS, Dunaif A, Urbanek M. Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocrinol Metab. 2013;98(1):E185-90.","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"1251_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/09513590.2014.895982","volume":"30","author":"YA Bassiouny","year":"2014","unstructured":"Bassiouny YA, Rabie WA, Hassan AA, Darwish RK. Association of the luteinizing hormone\/choriogonadotropin receptor gene polymorphism with polycystic ovary syndrome. Gynecol Endocrinol. 2014;30(6):428\u201330.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"1251_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10815-015-0427-0","volume":"32","author":"WY Almawi","year":"2015","unstructured":"Almawi WY, Hubail B, Arekat DZ, Al-Farsi SM, Al-Kindi SK, Arekat MR, Mahmood N, Madan S. Leutinizing hormone\/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome. J Assist Reprod Genet. 2015;32(4):607\u201314.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"1251_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/gtmb.2014.0249","volume":"19","author":"S Thathapudi","year":"2015","unstructured":"Thathapudi S, Kodati V, Erukkambattu J, Addepally U, Qurratulain H. Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome. Genet Test Mol Biomarkers. 2015;19(3):128\u201332.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"1","key":"1251_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/iub.1457","volume":"68","author":"AS El-Shal","year":"2016","unstructured":"El-Shal AS, Zidan HE, Rashad NM, Abdelaziz AM, Harira MM. Association between genes encoding components of the leutinizing hormone\/luteinizing hormone\u2013choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women. IUBMB Life. 2016;68(1):23\u201336.","journal-title":"IUBMB Life"},{"issue":"1","key":"1251_CR13","first-page":"43","volume":"12","author":"Z Shaaban","year":"2018","unstructured":"Shaaban Z, Shirazi MR, Nooranizadeh MH, Tamadon A, Rahmanifar F, Ahmadloo S, Ramezani A, Zamiri MJ, Jahromi IR, Sarvestani FS, Hosseinabadi OK. Decreased expression of arginine-phenylalanine-amide-related peptide-3 gene in dorsomedial hypothalamic nucleus of constant light exposure model of polycystic ovarian syndrome. International journal of fertility & sterility. 2018;12(1):43.","journal-title":"International journal of fertility & sterility"},{"key":"1251_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1877-1173(09)89004-2","volume":"89","author":"DL Segaloff","year":"2009","unstructured":"Segaloff DL. Diseases associated with mutations of the human lutropin receptor. Prog Mol Biol Transl Sci. 2009;89:97\u2013114.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"4","key":"1251_CR15","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1371\/journal.pmed.0050088","volume":"5","author":"N Kossack","year":"2008","unstructured":"Kossack N, Simoni M, Richter-Unruh A, Themmen AP, Gromoll J. Mutations in a novel, cryptic exon of the luteinizing hormone\/chorionic gonadotropin receptor gene cause male pseudohermaphroditism. PLoS Med. 2008;5(4):e88.","journal-title":"PLoS Med"},{"issue":"10","key":"1251_CR16","doi-asserted-by":"publisher","first-page":"e46682","DOI":"10.1371\/journal.pone.0046682","volume":"7","author":"L Casarini","year":"2012","unstructured":"Casarini L, Lispi M, Longobardi S, Milosa F, La Marca A, Tagliasacchi D, Pignatti E, Simoni M. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. Plos one. 2012;7(10):e46682.","journal-title":"Plos one."},{"issue":"2","key":"1251_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/edrv.23.2.0462","volume":"23","author":"M Ascoli","year":"2002","unstructured":"Ascoli M, Fanelli F, Segaloff DL. The lutropin\/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. 2002;23(2):141\u201374.","journal-title":"Endocr Rev"},{"issue":"5","key":"1251_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/humupd\/dmt023","volume":"19","author":"B Troppmann","year":"2013","unstructured":"Troppmann B, Kleinau G, Krause G, Gromoll J. Structural and functional plasticity of the luteinizing hormone\/choriogonadotrophin receptor. Hum Reprod Update. 2013;19(5):583\u2013602.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"1251_CR19","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1210\/er.2013-1121","volume":"35","author":"YX Tao","year":"2014","unstructured":"Tao YX, Conn PM. Chaperoning G protein-coupled receptors: from cell biology to therapeutics. Endocr Rev. 2014;35(4):602\u201347.","journal-title":"Endocr Rev"},{"key":"1251_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/bs.pmbts.2018.09.007","volume":"161","author":"J Qiao","year":"2019","unstructured":"Qiao J, Han B. Diseases caused by mutations in luteinizing hormone\/chorionic gonadotropin receptor. Prog Mol Biol Transl Sci. 2019;161:69\u201389.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"6","key":"1251_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499\u2013502.","journal-title":"Clin Chem"},{"issue":"2","key":"1251_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/clinchem\/36.2.261","volume":"36","author":"K Adeli","year":"1990","unstructured":"Adeli K, Ogbonna G. Rapid purification of human DNA from whole blood for potential application in clinical chemistry laboratories. Clin Chem. 1990;36(2):261\u20134.","journal-title":"Clin Chem"},{"issue":"1","key":"1251_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2265.2012.04372.x","volume":"77","author":"A Capalbo","year":"2012","unstructured":"Capalbo A, Sagnella F, Apa R, Fulghesu AM, Lanzone A, Morciano A, Farcomeni A, Gangale MF, Moro F, Martinez D, Ciardulli A. The 312 N variant of the luteinizing hormone\/choriogonadotropin receptor gene (LHCGR) confers up to 2\u00b77-fold increased risk of polycystic ovary syndrome in a Sardinian population. Clin Endocrinol. 2012;77(1):113\u20139.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1251_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng1706","volume":"38","author":"AD Skol","year":"2006","unstructured":"Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006;38(2):209\u201313.","journal-title":"Nat Genet"},{"issue":"1","key":"1251_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4755-12-7","volume":"12","author":"AS Jamil","year":"2015","unstructured":"Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T. A case\u2013control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. Reprod Health. 2015;12(1):1\u20139.","journal-title":"Reprod Health"},{"issue":"1","key":"1251_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12041-017-0749-z","volume":"96","author":"M Thangavelu","year":"2017","unstructured":"Thangavelu M, Godla UR, Paul SF, Maddaly R. Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome. J Genet. 2017;96(1):87\u201396.","journal-title":"J Genet"},{"issue":"4","key":"1251_CR27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/ahg.12020","volume":"77","author":"S Dasgupta","year":"2013","unstructured":"Dasgupta S, Reddy BM. The Role of Epistasis in the Etiology of Polycystic Ovary Syndrome among Indian Women: SNP-SNP and SNP-Environment Interactions. Ann Hum Genet. 2013;77(4):288\u201398.","journal-title":"Ann Hum Genet"},{"issue":"9","key":"1251_CR28","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.3390\/jcm9093024","volume":"9","author":"M Ka\u0142u\u017cna","year":"2020","unstructured":"Ka\u0142u\u017cna M, Cz\u0142apka-Matyasik M, Wachowiak-Ochma\u0144ska K, Moczko J, Kaczmarek J, Janicki A, Pi\u0105tek K, Rucha\u0142a M, Ziemnicka K. Effect of central obesity and hyperandrogenism on selected inflammatory markers in patients with PCOS: a WHtR-matched case-control study. J Clin Med. 2020;9(9):3024.","journal-title":"J Clin Med"},{"issue":"9","key":"1251_CR29","doi-asserted-by":"publisher","first-page":"e14712","DOI":"10.1097\/MD.0000000000014712","volume":"98","author":"K Ofer","year":"2019","unstructured":"Ofer K, Ronit L, Ophir A, Amir K. Normal body mass index (BMI) can rule out metabolic syndrome: an Israeli cohort study. Medicine. 2019;98(9):e14712.","journal-title":"Medicine."},{"issue":"5","key":"1251_CR30","first-page":"435","volume":"172","author":"R Kaur","year":"2021","unstructured":"Kaur R, Kaur M, Suri V. Phenotypic presentation of PCOS with respect to BMI in a north Indian population. Clin Ter. 2021;172(5):435\u20137.","journal-title":"Clin Ter."},{"issue":"10","key":"1251_CR31","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1073\/pnas.1523236113","volume":"113","author":"X Yuan","year":"2016","unstructured":"Yuan X, Hu T, Zhao H, Huang Y, Ye R, Lin J, Zhang C, Zhang H, Wei G, Zhou H, Dong M. Brown adipose tissue transplantation ameliorates polycystic ovary syndrome. Proc Natl Acad Sci. 2016;113(10):2708\u201313.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"1251_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3945\/an.115.010587","volume":"7","author":"LK Brahe","year":"2016","unstructured":"Brahe LK, Astrup A, Larsen LH. Can we prevent obesity-related metabolic diseases by dietary modulation of the gut microbiota? Adv Nutr. 2016;7(1):90\u2013101.","journal-title":"Adv Nutr"},{"issue":"3","key":"1251_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jpag.2011.11.009","volume":"25","author":"M Eleftheriadou","year":"2012","unstructured":"Eleftheriadou M, Michala L, Stefanidis K, Iliadis I, Lykeridou A, Antsaklis A. Exercise and sedentary habits among adolescents with PCOS. J Pediatr Adolesc Gynecol. 2012;25(3):172\u20134.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"11","key":"1251_CR34","doi-asserted-by":"publisher","first-page":"e80000","DOI":"10.1371\/journal.pone.0080000","volume":"8","author":"JY Chau","year":"2013","unstructured":"Chau JY, Grunseit AC, Chey T, Stamatakis E, Brown WJ, Matthews CE, Bauman AE, Van Der Ploeg HP. Daily sitting time and all-cause mortality: a meta-analysis. PLoS ONE. 2013;8(11):e80000.","journal-title":"PLoS ONE"},{"key":"1251_CR35","doi-asserted-by":"publisher","first-page":"537809","DOI":"10.3389\/fendo.2020.537809","volume":"11","author":"K Lin","year":"2021","unstructured":"Lin K, Sun X, Wang X, Wang H, Chen X. Circulating adipokine levels in non obese women with polycystic ovary syndrome and in nonobese control women: a systematic review and meta-analysis. Front Endocrinol. 2021;11:537809.","journal-title":"Front Endocrinol"},{"issue":"3","key":"1251_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijgo.2010.01.014","volume":"109","author":"A El-Mazny","year":"2010","unstructured":"El-Mazny A, Abou-Salem N, El-Sherbiny W, El-Mazny A. Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome. Int J Gynecol Obstet. 2010;109(3):239\u201341.","journal-title":"Int J Gynecol Obstet"},{"issue":"10","key":"1251_CR37","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3109\/09513590.2010.508852","volume":"27","author":"MP Rocha","year":"2011","unstructured":"Rocha MP, Marcondes JA, Barcellos CR, Hayashida SA, Curi DD, da Fonseca \u00c2M, Bagnoli VR, Baracat EC. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecol Endocrinol. 2011;27(10):814\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"1251_CR38","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","volume":"95","author":"RA Wild","year":"2011","unstructured":"Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95(3):1073\u20139.","journal-title":"Fertil Steril"},{"issue":"9","key":"1251_CR39","first-page":"1049","volume":"64","author":"A Hussain","year":"2014","unstructured":"Hussain A, Alam JM. Dyslipidaemia in woman with polycystic ovarian syndrome: A case control study in tertiary care hospital of Karachi. J Pak Med Assoc. 2014;64(9):1049\u201352.","journal-title":"J Pak Med Assoc"},{"issue":"8","key":"1251_CR40","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1177\/1933719114522525","volume":"21","author":"NM Clark","year":"2014","unstructured":"Clark NM, Podolski AJ, Brooks ED, Chizen DR, Pierson RA, Lehotay DC, Lujan ME. Prevalence of polycystic ovary syndrome phenotypes using updated criteria for polycystic ovarian morphology: an assessment of over 100 consecutive women self-reporting features of polycystic ovary syndrome. Reprod Sci. 2014;21(8):1034\u201343.","journal-title":"Reprod Sci"},{"issue":"1\u20132","key":"1251_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mce.2007.06.007","volume":"276","author":"D Piersma","year":"2007","unstructured":"Piersma D, Verhoef-Post M, Look MP, Uitterlinden AG, Pols HA, Berns EM, Themmen AP. Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer. Mol Cell Endocrinol. 2007;276(1\u20132):63\u201370.","journal-title":"Mol Cell Endocrinol"},{"key":"1251_CR42","doi-asserted-by":"publisher","unstructured":"Makhdoomi MJ, Shah I, Rashid R, Rashid A, Shah ZA, Ganie MA. Effect modification of luteinizing hormone chorionic gonadotropin hormone receptor gene variant (rs2293275) on clinical and biochemical profile, and levels of luteinizing hormone in polycystic ovary syndrome patients. https:\/\/doi.org\/10.1093\/humrep\/8.suppl_2.123.","DOI":"10.1093\/humrep\/8.suppl_2.123"},{"key":"1251_CR43","first-page":"1","volume":"29","author":"MF Atoum","year":"2022","unstructured":"Atoum MF, Alajlouni MM, Alzoughool F. A Case-Control Study of the Luteinizing Hormone Level in Luteinizing Hormone Receptor Gene (rs2293275) Polymorphism in Polycystic Ovarian Syndrome Females. Public Health Genomics. 2022;29:1\u20139.","journal-title":"Public Health Genomics"},{"issue":"8","key":"1251_CR44","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1093\/humrep\/dep113","volume":"24","author":"O Valkenburg","year":"2009","unstructured":"Valkenburg O, Uitterlinden AG, Piersma D, Hofman A, Themmen AP, De Jong FH, Fauser BC, Laven JS. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum Reprod. 2009;24(8):2014\u201322.","journal-title":"Hum Reprod"},{"issue":"12","key":"1251_CR45","doi-asserted-by":"publisher","first-page":"e0209830","DOI":"10.1371\/journal.pone.0209830","volume":"13","author":"U Branavan","year":"2018","unstructured":"Branavan U, Muneeswaran K, Wijesundera S, Jayakody S, Chandrasekharan V, Wijeyaratne C. Identification of selected genetic polymorphisms in polycystic ovary syndrome in Sri Lankan women using low cost genotyping techniques. PLoS ONE. 2018;13(12):e0209830.","journal-title":"PLoS ONE"},{"issue":"6","key":"1251_CR46","doi-asserted-by":"publisher","first-page":"102202","DOI":"10.1016\/j.jksus.2022.102202","volume":"34","author":"MC Alarc\u00f3n-Granados","year":"2022","unstructured":"Alarc\u00f3n-Granados MC, Moreno-Ort\u00edz H, Rond\u00f3n-Lagos M, Camargo-Villalba GE, Forero-Castro M. Study of LHCGR gene variants in a sample of colombian women with polycystic ovarian syndrome: A pilot study. Journal of King Saud University-Science. 2022;34(6):102202.","journal-title":"Journal of King Saud University-Science"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01251-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01251-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01251-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T16:03:27Z","timestamp":1672416207000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01251-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01251-9","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]},"assertion":[{"value":"21 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of Guru Nanak Dev University (297\/HG), consistent with provisions of the Declaration of Helsinki and informed consent was taken from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"There was no personal data in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"335"}}